The required experience of open pancreaticoduodenectomy before becoming a specialist inhepatobiliary and pancreatic surgeons: A multicenter, cohort study of 334 open pancreaticoduodenectomies
Tomokazu Fuji(Okayama University), Toshiyoshi Fujiwara(Okayama University), Toshiharu Mitsuhashi(Okayama University Hospital), Daisuke Nobuoka(Fukuyama City Hospital), Yuzo Umeda(Okayama University), Kazuya Yasui(Okayama University), Yoshikatsu Endo(Himeji Red Cross Hospital), Masayoshi Hioki(Fukuyama City Hospital), Kosei Takagi(Okayama Shoka University), Ryuichi Yoshida(Okayama University)
Cited by 0
Related Papers
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
|Molecular Cancer Therapeutics|2021|258
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
|OncoImmunology|2016|178
AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer
|JCI Insight|2018|148
The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer
|Journal of Experimental & Clinical Cancer Research|2018|111